Home › Funds › Samsara BioCapital, LLC › JBIO

Samsara BioCapital, LLC position in JBIO

JADE BIOSCIENCES INC · Health Care

Samsara BioCapital, LLC reported holding 736,237 shares of JBIO (JADE BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$16.4M, representing 1.34% of its reported portfolio and ranking #11 among its reported holdings. Samsara BioCapital, LLC has disclosed JBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)736.24K sh
Reported value held$16.36M
Portfolio Weight1.34%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's JBIO position evolved

Samsara BioCapital, LLC first disclosed a stake in JBIO in Q2 2025 at 531,163 shares (US$5.3M). The position peaked in Q2 2026 at 736,237 shares, worth US$16.4M. Across 5 filings, Samsara BioCapital, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 736,237 shares valued at US$16.4M — a reduction of -232,561 shares quarter over quarter.. Notable position changes include a 82% increase in Q4 2025 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 531.16K $5.31M New
Q3 2025 531.16K $4.58M Hold
Q4 2025 968.80K $14.95M Add
Q1 2026 968.80K $13.61M Hold
Q2 2026 736.24K $16.36M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JBIO and 13F data

JBIO (JADE BIOSCIENCES INC) is a Health Care company. 106 other funds we track also report a position in JBIO — the largest reported positions include Fairmount Funds Management LLC (US$101.2M), RA CAPITAL MANAGEMENT, L.P. (US$81.6M), Venrock Adviser, LLC (US$71.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JBIO

All JBIO fund holders →

FAQ

How long has Samsara BioCapital, LLC held JBIO?

Samsara BioCapital, LLC has disclosed JBIO holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Samsara BioCapital, LLC's current position in JBIO?

As of Q2 2026, Samsara BioCapital, LLC holds 736.24K shares of JBIO (JADE BIOSCIENCES INC), valued at $16.36M, representing 1.34% of its reported portfolio and ranking #11.

Has Samsara BioCapital, LLC been buying or selling JBIO?

In the latest 13F filing (Q2 2026), Samsara BioCapital, LLC reduced its position in JBIO. The position peaked in Q2 2026 at 736.24K shares.

Which other funds hold JBIO?

Other major institutional holders of JBIO include Fairmount Funds Management LLC, RA CAPITAL MANAGEMENT, L.P., Venrock Adviser, LLC, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.